Octant
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $115M
Investors
- 13
About Octant
Octant, Inc.Founded in 2017 in Tukwila, US, Octant, Inc. specializes in biotechnology solutions.00 mn.Octant specializes in the development of next-generation small molecules aimed at modulating complex cellular mechanisms that drive diseases, particularly those related to protein misfolding and mistrafficking. The company's innovative approach integrates advanced synthetic biology and high-throughput chemistry to create custom sensors within human cells, allowing for detailed modeling of cellular functions and disease mechanisms. This technology facilitates the identification of how drug candidates interact with specific proteins and affect cellular outcomes. Octant primarily serves biopharmaceutical companies engaged in drug discovery and development across various geographical markets, including North America, Europe, and Asia.Octant's revenue model is structured around B2B partnerships and collaborations with pharmaceutical companies seeking to leverage their advanced drug discovery technologies. The company engages in transactions that typically involve contractual agreements for access to its proprietary platforms and datasets, tailored to client-specific drug development needs. Clients may participate in long-term partnerships that provide them with ongoing access to Octant’s high-throughput drug discovery capabilities, potentially under subscription agreements or project-based contracts. Specific pricing plans and terms are negotiated based on the scope and scale of engagement, which may include milestone-based payments associated with the advancement of drug candidates through various stages of development.In April 2022, Octant, Inc. The company is focusing on expanding its reach into more global markets and aims to enhance its capabilities in creating advanced small molecules for drug discovery.
Who invested in Octant
13 investors across 3 rounds
See all investors in Octant
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Octant
Who invested in Octant?
Octant has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Octant raised?
Octant has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Octant last raise money?
Octant's most recent round on record is a Series B, in Apr 2022.
What does Octant do?
Octant is a biotechnology company.
Where is Octant headquartered?
Octant is headquartered in Tukwila, US.
Which VCs invest in companies like Octant?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Octant's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Octant? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.